Turkish validation of a breathing symptoms questionnaire in COPD
Part of Lungs & breathing clinical trials.
This study tests a Turkish version of a questionnaire that measures breathing-related symptoms in people with stable COPD. It aims to ensure the questionnaire is accurate and useful for Turkish-speaking patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with COPD by a doctor
- Your COPD has been stable for at least 4 weeks (no flare-ups or hospital stays)
- You can read and understand Turkish
- You are willing to be part of the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at signs (biomarkers) and different types of COPD in Chinese people. It aims to better understand COPD and pre-COPD, which may help with future treatments.
This trial tests how well different breathing tests measure relief from shortness of breath in people with asthma or COPD. It may help doctors find better ways to check how well treatments are working.
This study looks at how a breathing-related questionnaire (called the Multidimensional Dyspnea Profile) measures changes in shortness of breath during lung rehabilitation for people with COPD. It aims to find out what a 'meaningful' improvement feels like, so doctors can better track your progress.
This study aims to find people with undiagnosed asthma or COPD by using a simple questionnaire and a breathing test. If you have symptoms like cough or wheeze but no prior diagnosis, you may be able to join and get early treatment.
This study checks whether a Turkish questionnaire about how people notice their own breathing is accurate and reliable. Researchers are collecting feedback from healthy people to make sure the survey works well for everyone who uses it.
This study checks whether a Turkish version of a symptom questionnaire works reliably for people with idiopathic pulmonary fibrosis. It may help clinics better understand symptoms and track changes over time.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.